Holen Sie sich die Stockscreener-App
7.34
3.67%
-0.28
Handel nachbörslich:
7.35
0.010
+0.14%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$7.62
Offen:
$7.49
24-Stunden-Volumen:
2.77M
Relative Volume:
0.72
Marktkapitalisierung:
$1.19B
Einnahmen:
$1.08B
Nettoeinkommen (Verlust:
$422.82M
KGV:
3.2193
EPS:
2.28
Netto-Cashflow:
$-637.33M
1W Leistung:
+9.23%
1M Leistung:
+8.26%
6M Leistung:
+4.26%
1J Leistung:
-23.58%
1-Tages-Spanne:
$7.31
$7.55
1-Wochen-Bereich:
$6.76
$7.755
52-Wochen-Spanne:
$5.01
$10.64
Novavax Inc Stock (NVAX) Company Profile
Firmenname
Novavax Inc
Sektor
Branche
Telefon
240-268-2000
Adresse
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Vergleichen Sie NVAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
7.34 | 1.24B | 1.08B | 422.82M | -637.33M | 2.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-24 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-08-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-08-20 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-06-17 | Eingeleitet | Citigroup | Sell |
| 2025-02-28 | Eingeleitet | BTIG Research | Buy |
| 2024-07-30 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-05-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-05-10 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-08-09 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | Bestätigt | B. Riley Securities | Buy |
| 2022-12-30 | Bestätigt | H.C. Wainwright | Buy |
| 2022-12-02 | Eingeleitet | Jefferies | Hold |
| 2022-09-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-05-20 | Eingeleitet | BofA Securities | Underperform |
| 2022-02-23 | Bestätigt | B. Riley Securities | Buy |
| 2022-02-22 | Fortgesetzt | Jefferies | Buy |
| 2022-01-21 | Eingeleitet | Cowen | Outperform |
| 2021-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-12-14 | Eingeleitet | Jefferies | Buy |
| 2020-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-08-05 | Herabstufung | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | Bestätigt | B. Riley FBR | Buy |
| 2020-06-29 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-05 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-05-28 | Bestätigt | B. Riley FBR | Buy |
| 2020-05-12 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-30 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-08-14 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-28 | Herabstufung | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-12-11 | Eingeleitet | Oppenheimer | Outperform |
| 2018-11-26 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2018-03-29 | Hochstufung | Seaport Global Securities | Neutral → Buy |
Alle ansehen
Novavax Inc Aktie (NVAX) Neueste Nachrichten
Is Novavax Inc. stock overvalued by current metricsQuarterly Portfolio Review & Safe Swing Trade Setup Alerts - ulpravda.ru
Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Nasdaq
Is Novavax (NVAX) Mispriced After Recent Share Rebound And DCF Upside Projection - Yahoo Finance UK
Novavax Sees Unusually Large Options Volume (NASDAQ:NVAX) - MarketBeat
Assessing Novavax (NVAX) Valuation After Recent Share Price Momentum And Mixed Analyst Targets - Yahoo Finance
The Technical Signals Behind (NVAX) That Institutions Follow - Stock Traders Daily
Novavax (NVAX) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
CDC overhauls childhood vaccine schedule (PFE:NYSE) - Seeking Alpha
Q3 Earnings Outperformers: Novavax (NASDAQ:NVAX) And The Rest Of The Therapeutics Stocks - Yahoo Finance
Novavax Inc. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Novavax stock today: NVAX closes up 6% as Singapore rolls out JN.1 Novavax COVID shot - ts2.tech
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Novavax (NVAX) Stock Trades Up, Here Is Why - The Globe and Mail
Novavax (NVAX) Stock Up 3% as JN.1 COVID-19 Vaccine Launches in Singapore ClinicsNews and Statistics - IndexBox
Risk Hedge: Is Novavax Inc NVV1 stock undervalued after correctionEarnings Beat & Real-Time Buy Signal Alerts - moha.gov.vn
Aug Analyst Calls: Should I hold or sell Novavax Inc stock in 2025July 2025 Weekly Recap & Stepwise Trade Execution Plans - moha.gov.vn
Novavax (NASDAQ:NVAX) Surprises With Q3 CY2025 Sales - Yahoo Finance
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - sharewise.com
Novavax, Inc. (NVAX) Stock Analysis: Navigating the 87% Potential Upside Amidst Biotech Volatility - DirectorsTalk Interviews
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Novavax (NVAX), Xenon (XENE) and Biohaven Ltd. (BHVN) - The Globe and Mail
Investor Mood: How strong is Novavax Inc stock balance sheetJuly 2025 Chart Watch & Accurate Buy Signal Notifications - moha.gov.vn
NVAX Stock Today: Can Novavax Turn Regulatory Turmoil and Activist Pressure into a Comeback? - ts2.tech
Trading Systems Reacting to (NVAX) Volatility - Stock Traders Daily
Novavax (NVAX) Is Up 6.3% After Activist Sale Push and Sanofi-Focused Royalty PivotWhat's Changed - simplywall.st
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
What valuation multiples suggest for Novavax Inc stockWeekly Gains Report & Weekly Watchlist of Top Performers - moha.gov.vn
Evaluating Novavax’s Current Valuation After Steep Five Year Share Price Collapse - Yahoo Finance
Why Novavax Inc. stock is favored by pension fundsJuly 2025 Final Week & Consistent Profit Trade Alerts - Улправда
Will Novavax Inc. stock gain from strong economyWeekly Profit Recap & Fast Moving Trade Plans - Bölüm Sonu Canavarı
Will Novavax Inc. stock outperform international peersQuarterly Portfolio Review & Weekly Top Gainers Trade List - ulpravda.ru
Interesting NVAX Call Options For February 2026 - Nasdaq
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance
Should I hold or sell Novavax Inc. stock in 2025Trade Performance Summary & Low Risk High Win Rate Picks - DonanımHaber
Why Novavax Inc. stock is trending among retail traders2025 Volume Leaders & Stepwise Entry and Exit Trade Signals - DonanımHaber
Market Trends: Why Novavax Inc. stock remains a top recommendationTrade Volume Report & Verified Stock Trade Ideas - DonanımHaber
What hedge fund activity signals for Novavax Inc. stockWatch List & Free Accurate Trade Setup Notifications - DonanımHaber
Novavax Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
How strong is Novavax Inc. stock balance sheet2025 Technical Overview & Community Verified Watchlist Alerts - Bölüm Sonu Canavarı
Pfizer leads COVID-19 vaccine peers lower after revamped guidance - Seeking Alpha
Novavax, Inc. (NVAX) Stock Analysis: Exploring a Potential 92.5% Upside Amidst Market Challenges - DirectorsTalk Interviews
VP Casey Acquires 29,186 Of Novavax Inc [NVAX] - TradingView — Track All Markets
Novavax Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Avoiding Lag: Real-Time Signals in (NVAX) Movement - news.stocktradersdaily.com
Revenue Check: Why Novavax Inc stock is trending among retail traders2025 Top Decliners & Stepwise Swing Trade Plans - moha.gov.vn
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
FDA intends to put most serious warning on COVID vaccines, CNN reports - Reuters
CDC study finds COVID shot significantly reduced ER visits for children - Seeking Alpha
Why I wouldn't touch Novavax with a 10-foot pole - MSN
Why I Wouldn't Touch Novavax With a 10-Foot Pole - Yahoo Finance
Novavax Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Finanzdaten der Novavax Inc-Aktie (NVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Novavax Inc-Aktie (NVAX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Draghia-Akli Ruxandra | Section 16 |
Nov 11 '25 |
Option Exercise |
0.00 |
14,257 |
0 |
14,257 |
| MCGLYNN MARGARET G | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
25,588 |
| Alton Gregg H | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
28,805 |
| King Rachel K. | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
25,190 |
| Rodgers Richard J | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
24,690 |
| MOTT DAVID M | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
60,890 |
| DOUGLAS RICHARD | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
54,340 |
0.80%
4.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):